Smoking cessation in the management of Chronic Obstructive Pulmonary Disease (COPD): narrative review and recommendations
Authors
Rosastella Principe, Vincenzo Zagà, Paola Martucci, Loreta Di Michele, Carlo Barbetta, Antonella Serafini, Maria Sofia Cattaruzza, Claudia Giacomozzi
Abstract
Background. The percentage of smokers who develop COPD (chronic obstructive pulmonary disease) peaks at 40-50% in most recent publications.
Summary. Tobacco smoke remains the main cause of COPD, though smoking-related limitation of the flow is rather subjective. For patients who keep on smoking, general practitioners (GPs) and pulmonologists should be able to offer smoking cessation programs as an important part of COPD treatment. This narrative article aims to provide the scientific basis to help healthcare professionals develop this therapy; with this aim in mind, the authors have analyzed the most recent literature.
Key messages. Only 3% of smokers who try to quit without availing themselves of any support succeed. Effective smoking cessation methods are Counselling and Pharmacotherapy, which, combined together, are credited with a 24% success rate. Although there are no therapeutic novelties with strong scientific evidence for smoking cessation, it is however advisable to keep the literature updated to new devices and new digital therapies.
PDF
